Prognostic Significance of Epidermal Growth Factor Receptor in Patients of Glioblastoma Multiforme
Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 8
Abstract
Introduction: Glioblastoma Multiforme (GBM) is the most aggressive glial tumour with hallmark characteristics of rampant proliferation of glial cells along with high pleomorphism, necrosis, endothelial proliferation and high MIB-1 labeling index (cell proliferation marker). These tumours are managed by surgery followed by Radiotherapy (RT), Chemotherapy (CT) and adjuvant CT Temozolomide (TMZ). Aim: To evaluate Epidermal Growth Factor Receptor (EGFR) protein expression in GBM patients. Materials and Methods: The study comprised of 52 cases of GBM diagnosed by histomorphology from biopsy specimens. Ancillary techniques like Immunohistochemistry (IHC) for Glial Fibrillary Acidic Protein (GFAP), cell proliferation marker (MIB-1 labeling index, P53 expressions) were done in all cases. EGFR protein expression was assessed by IHC as the percentage of positive tumour cells in hot spots (10 high power fields). Response to therapy was assessed at three months post therapy by using World Health Organization (WHO) Response Evaluation Criteria In Solid Tumours (RECIST) guideline. Statistical analysis was performed by using IBM-Statistical Package for Social Sciences (SPSS) software, version 20. The p-value of ≤ 0.05 was considered significant. The mean survival of the patients was calculated using unpaired t-test and ANOVA (analysis of variance) test. Results: Out of 52 cases, thirty cases was EGFR positive and 22 cases were EGFR negative. Response to therapy was evident in 33 (63.5%) cases and 19 cases (36.5%) were non responders. The responders with EGFR negative were 86.4% and EGFR positive were 46.7% with a p-value of 0.003. The mean survival among EGFR positive and negative GBM were 315.73±257.54 and 657.91±305.88 days respectively with a significant p-value of 0.001. Conclusion: EGFR negative patients respond better to therapy along with longer duration of survival as compared to EGFR positive patient.
Authors and Affiliations
Kalpalata Tripathy, Bidyutprava Das, Ajit Kumar Singh, Aparajita Misra, Sanjib Misra, Sudhansu Sekhar Misra
Keywords
Related Articles
- EP ID EP358188
- DOI 10.7860/JCDR/2017/30138.10327
- Views 65
- Downloads 0
Role of Serum Cystatin C Levels in Preterm Neonates with Respiratory Distress Syndrome in Diagnosing Neonatal AKI
ABSTRACT Introduction: Despite major advances in perinatal and neonatal care in Respiratory Distress Syndrome (RDS) prevention and treatment, a considerable number of these neonates suffer from RDS along with Acute Kidne...
Sinus Rhythm in Rheumatic Mitral Stenosis after Balloon Mitral Valvotomy: Is it Feasible?
Introduction: Atrial Fibrillation (AF) is largely present in patients with rheumatic valvular disease, leading to hospitalizations. Aim: We aimed to study the restoration and maintenance of Sinus Rhythm (SR) in rheumatic...
Scintigraphic Profile of Thyrotoxicosis Patients and Correlation with Biochemical and Sonological Findings
Introduction: Thyrotoxicosis is a spectrum of disorder with a rather common clinical presentation with different aetiologies. The aetiological diagnosis is important as the management differs. It is essential to accurate...
Outcome of Drug Resistant Severe Atrial Tachycardia During Pregnancy treated with Catheter Ablation
ABSTRACT A 24-year-old primigravid woman at 28 weeks of gestation was admitted to the hospital because of drug-refractory atrial tachycardia and heart failure. The arrhythmia did not respond to drug therapy and electric...
Histogenesis of Thyroid Gland in Dead Human Foetuses of Different Gestational Age
ABSTRACT Introduction: In human beings the thyroid gland is one of the largest differentiated endocrine gland. The function of thyroid gland is to promote growth and development of the brain during foetal life and for t...